⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9328484 | 0.93 | — | — | |
| SCHEMBL25176763 | 0.82 | — | — | |
| SCHEMBL19348691 | 0.82 | — | — | |
| Trimethyl Phosphate SCHEMBL19941 | 0.76 | — | — | |
| SCHEMBL7478684 | 0.76 | — | — | |
| SCHEMBL10365031 | 0.76 | — | — | |
| Trimethyl Phosphate SCHEMBL2356985 | 0.72 | — | — | |
| Trimethyl Phosphate SCHEMBL298751 | 0.72 | — | — | |
| Trimethyl Phosphate SCHEMBL7705188 | 0.72 | — | — | |
| Trimethyl Phosphate SCHEMBL2356992 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001399-B | Imidic acid compound and its manufacturing method with dianion | 中央硝子株式会社 | 2019-06-14 | — | — | CN | disclosed |
| CN-107001399-A | Imidic acid compound and its manufacture method with dianion | 中央硝子株式会社 | 2017-08-01 | — | — | CN | disclosed |
| CN-101845009-B | Structural carotenoid analogs for the inhibition and amelioration of disease | HAWAII BIOTECH INC | 2012-10-03 | — | — | CN | disclosed |
| EP-2392562-A1 | Structural carotenoid analogs for the inhibition and amelioration of disease | Cardax Pharmaceuticals, Inc. (US) | 2011-12-07 | — | — | EP | disclosed |
| CN-1708480-B | Carotenoid structural analogs for inhibiting and ameliorating disease | HAWAII BIOTECH INC | 2010-12-15 | — | — | CN | disclosed |
| CN-101845009-A | Be used to suppress and improve the structural carotenoid analogs of disease | HAWAII BIOTECH INC | 2010-09-29 | — | — | CN | disclosed |
| US-7763649-B2 | Carotenoid analogs or derivatives for controlling connexin 43 expression | CARDAX PHARMACEUTICALS, INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-7723327-B2 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease | CARDAX PHARMACEUTICALS, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7592449-B2 | Structural carotenoid analogs for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-7521584-B2 | Carotenoid analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-20050059635-A1 | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels | CARDAX PHARMACEUTICALS, INC. | 2005-03-17 | — | — | US | disclosed |
| US-20050049248-A1 | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels | CARDAX PHARMACEUTICALS, INC. | 2005-03-03 | — | — | US | disclosed |
| US-20050037995-A1 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury | CARDAX PHARMA, INC. | 2005-02-17 | — | — | US | disclosed |
| US-20050026874-A1 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease | CARDAX PHARMACEUTICALS, INC. | 2005-02-03 | — | — | US | disclosed |
| US-20050009930-A1 | Carotenoid analogs or derivatives for controlling connexin 43 expression | CARDAX PHARMA, INC. | 2005-01-13 | — | — | US | disclosed |
| US-20050009788-A1 | Carotenoid ester analogs or derivatives for controlling connexin 43 expression | CARDAX PHARMACEUTICALS, INC. | 2005-01-13 | — | — | US | disclosed |
| US-20050009758-A1 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMA, INC. | 2005-01-13 | — | — | US | disclosed |
| US-20050004235-A1 | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease | CARDAX PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | disclosed |
| US-20040162329-A1 | Structural carotenoid analogs for the inhibition and amelioration of disease | CARDAX PHARMA, INC. | 2004-08-19 | — | — | US | disclosed |
| WO-2004011423-A2 | STRUCTURAL CAROTENOID ANALOGS FOR THE INHIBITION AND AMELIORATION OF DISEASE | HAWAII BIOTECH, INC. (US) | 2004-02-05 | — | — | WO | disclosed |